Smith & Nephew SNATS, Inc. (SNN) to Issue Dividend of $0.48 on May 27th

Smith & Nephew SNATS, Inc. (NYSE:SNN) declared a dividend on Thursday, March 5th. Stockholders of record on Friday, March 27th will be paid a dividend of 0.482 per share by the medical equipment provider on Wednesday, May 27th. This represents a dividend yield of 281.0%. The ex-dividend date is Friday, March 27th.

Smith & Nephew SNATS has increased its dividend payment by an average of 0.0%per year over the last three years. Smith & Nephew SNATS has a dividend payout ratio of 26.0% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Smith & Nephew SNATS to earn $2.00 per share next year, which means the company should continue to be able to cover its $0.57 annual dividend with an expected future payout ratio of 28.5%.

Smith & Nephew SNATS Trading Down 1.6%

NYSE:SNN opened at $34.29 on Friday. The company has a quick ratio of 1.40, a current ratio of 2.57 and a debt-to-equity ratio of 0.60. The company has a 50 day moving average price of $34.43 and a 200 day moving average price of $34.94. Smith & Nephew SNATS has a fifty-two week low of $23.91 and a fifty-two week high of $38.79.

Institutional Investors Weigh In On Smith & Nephew SNATS

A number of large investors have recently modified their holdings of SNN. Garner Asset Management Corp acquired a new stake in shares of Smith & Nephew SNATS in the 4th quarter valued at $27,000. Arax Advisory Partners grew its stake in shares of Smith & Nephew SNATS by 142.6% during the fourth quarter. Arax Advisory Partners now owns 968 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 569 shares in the last quarter. Advisors Asset Management Inc. acquired a new position in shares of Smith & Nephew SNATS during the fourth quarter worth $36,000. Caitong International Asset Management Co. Ltd purchased a new position in Smith & Nephew SNATS in the third quarter valued at $41,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in Smith & Nephew SNATS in the fourth quarter valued at $43,000. 25.64% of the stock is owned by hedge funds and other institutional investors.

About Smith & Nephew SNATS

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.